Evidence map›Paper›PMID 36614421›Full record

ArticleMaterials (Basel, Switzerland)2022

Development of New Azomethine Metal Chelates Derived from Isatin: DFT and Pharmaceutical Studies.

Abdulrhman A Al-Shamry, Mai M Khalaf, Hany M Abd El-Lateef, Tarek A Yousef, Gehad G Mohamed, Kariman M Kamal El-Deen, Mohamed Gouda, Ahmed M Abu-Dief

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Abdulrhman A Al-ShamryDepartment of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Mai M KhalafDepartment of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-0599-9928
Hany M Abd El-LateefDepartment of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-6610-393X
Tarek A YousefDepartment of Chemistry, Science College, Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box 90950, Riyadh 11623, Saudi Arabia.ORCID 0000-0003-3039-7646
Gehad G MohamedChemistry Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Kariman M Kamal El-DeenChemistry Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Mohamed GoudaDepartment of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-7864-4151
Ahmed M Abu-DiefDepartment of Chemistry, Faculty of Science, Sohag University, Sohag 82534, Egypt.ORCID 0000-0003-3771-9011
King Faisal University · SACairo University · EGImam Mohammad ibn Saud Islamic University · SATaibah University · SA

Funding

King Faisal University GRANT1,946
6 · The paper itself

Abstract

Through the condensation of isatin (indoline-2, 3-dione) and aniline in a 1:1 ratio, a Schiff base ligand was synthesized and characterized via (

Indexed as

anticancer activityantimicrobial screeningisatin Schiff base ligandspectroscopic

Identifiers

PMID36614421
PMCPMC9821024
OpenAlexW4312187157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.